Akèy › Maladi poumon entèstisyèl › South Carolina
Etid klinik pou Maladi poumon entèstisyèl nan South Carolina
14 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan South Carolina.
Vil nan South Carolina
Tèks ofisyèl etid la (Anglè)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Lowcountry Lung and Critical Care, Charleston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Medical University of South Carolina, Charleston
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- MUSC, Charleston
- Velocity Clinical Research, Spartanburg
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
- Medical University of South Carolina, Charleston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07269262A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Medical University of South Carolina, Charleston
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Medical University of South Carolina, Charleston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Charleston
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- AnMed Health, Anderson
- Medical University of South Carolina, Charleston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Medical University of South Carolina (MUSC), Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Medical University of South Carolina, Charleston
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Medical University of South Carolina-Nexus, Charleston
- Prisma Health Pulmonology-Richland, Columbia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Medical University of South Carolina, Charleston
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Jun 26, 2026 · NCT06129240Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Bogan Sleep Consultants, LLC, Columbia
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.